Clinical Trials in Illinois

Showing 4581-4600 of 14,943 trials

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

Immune Thrombocytopenia

Sobi, Inc.60 participantsStarted Mar 2021

Tucson, Arizona, United States • Whittier, California, United States • Washington D.C., District of Columbia, United States +17 more locations

COMPLETEDPhase 4125 miles

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

NCT04054193

The purpose of this study is to evaluate the safety and tolerability of a 3-day intravenous (IV) fosaprepitant dimeglumine (MK-0517) regimen for the prevention of CINV in pediatric participants scheduled to receive emetogenic chemotherapy. Each participant was enrolled in Cycle 1 (on which the primary study objectives were based), consisting of the 3-day treatment cycle and 14 days of follow-up for a total of 17 days.

Chemotherapy-induced Nausea and Vomiting

Merck Sharp & Dohme LLC103 participantsStarted Sep 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Chicago, Illinois, United States +23 more locations

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Find Trials by Condition in Illinois

Saypha® VOLUME Lidocaine for Midface Augmentation

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection

Safety and Effectiveness of the Hydrus Microstent

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Evaluating Treatment of ADHD in Children with Down Syndrome

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

The Syn-Sleep Study

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors